Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-10 | New | $120,250 | $120,250 | Equity Only | 06b | SEC link |
| 2025-04-09 | New | $300,000 | $300,000 | Debt Only | 06b | SEC link |
| 2022-04-22 | New | $1,524,994 | $1,524,994 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Michael J. Aiello | Executive |
| Salvatore Alesci | Executive |
| Kerrie Brady | Director |
| Stephen Doberstein | Director |
| Aman Kant | Executive |
| Demetrios Kydonieus | Director |
| Sandeep Laumas | Director |
| Vimal Mehta | Director |
| Krishnan Nandabalan | Director, Executive |
| Shunichiro "Steve" Okada | Executive |
| Jonathan Zalevsky | Director |